Effectiveness of everolimus for sporadic renal angiomyolipoma with inferior vena cava thrombus: A case report
暂无分享，去创建一个
[1] H. Weiner,et al. Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations. , 2021, Pediatric neurology.
[2] M. Abdessater,et al. Renal angiomyolipoma with IVC thrombus: A case report , 2020, International journal of surgery case reports.
[3] S. Boorjian,et al. Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus (SAGE): Results of a Phase II Trial. , 2020, The Journal of urology.
[4] K. Bensalah,et al. Management of Sporadic Renal Angiomyolipomas: A Systematic Review of Available Evidence to Guide Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel. , 2020, European urology oncology.
[5] Oren Pleniceanu,et al. mTORC1 Inhibition Is an Effective Treatment for Sporadic Renal Angiomyolipoma , 2017, Kidney international reports.
[6] T. Sugai,et al. Efficacy of Everolimus for Treating Renal Angiomyolipoma with Inferior Vena Cava Thrombus Associated with Tuberous Sclerosis: A Case Report , 2017, Urology case reports.
[7] M. Fischereder,et al. Nephron-sparing resection of angiomyolipoma after sirolimus pretreatment in patients with tuberous sclerosis , 2012, International Urology and Nephrology.
[8] A. Folpe,et al. Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms. , 2007, Human pathology.